ReviewBiomedicines2025

PARP Inhibitors in Ovarian Cancer: Resistance Mechanisms, Clinical Evidence, and Evolving Strategies.

Shant Apelian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.